Every rehab website says the same three things: evidence-based care, individualized treatment, compassionate staff. None of it is falsifiable, and none of it tells you whether the place will actually help your loved one. Admissions counselors know the standard questions families ask — insurance coverage, length of stay, whether the facility "treats addiction" — and they have polished answers ready for all of them.
What separates a good decision from a lucky guess is the second question. Not "do you treat co-occurring disorders," but "show me what happens when a patient's depression gets worse in week two." Not "what's your success rate," but "how do you define success, and who measured it." Families researching dual diagnosis treatment programs often stop after getting a yes-or-no answer, when the real information lives in the follow-up.
This piece isn't a checklist of what to ask — plenty of those exist. It's a guide to the second question: the one that turns a marketing answer into a real one. If you haven't already, it's worth using our assessment tool to clarify what your loved one actually needs before you start interrogating admissions staff, and browsing our center directory to compare programs side-by-side rather than evaluating facilities one at a time in isolation.
Why the First Answer Is Almost Always Useless
Admissions departments are, functionally, sales departments. A 2021 analysis in the Journal of Substance Abuse Treatment found that marketing language across licensed U.S. treatment facilities showed strikingly little variation — "personalized care," "holistic healing," and "evidence-based" appeared on the majority of websites studied, regardless of the actual clinical model used inside. The words are not lies, exactly. They're just uninformative. Almost every center will say yes to "do you individualize treatment plans." Almost none will elaborate unprompted on what that individualization actually consists of.
This is not necessarily deception. Admissions staff are often not clinicians. They're trained to answer the question in front of them, reassure a frightened family member, and move the intake process forward. The person answering the phone frequently doesn't know the clinical director's actual protocol for medication adjustments, and has no reason to volunteer information nobody asked for.
That's the gap this article addresses: not what to ask first, but what to ask next — the question that forces a specific, checkable answer instead of a brand slogan.
"How Do You Individualize Treatment?" → "Walk Me Through One Actual Adjustment"
Every program claims individualized care. Push past it.
Ask: "Give me an example — not identifying details, just a scenario — of a patient whose plan changed mid-treatment because something wasn't working. What changed, and who decided?"
A program that actually individualizes care will have an answer immediately, because it happens constantly: a patient's anxiety spiked so the therapy frequency increased, a medication caused side effects so the psychiatrist swapped it, a patient wasn't engaging in group so they were moved to a smaller cohort. A program that recites individualization as a slogan will stumble, because there's no real internal process generating that kind of story.
The Follow-Up That Reveals the Model
Ask who makes that call. Is it a single case manager, a full multidisciplinary team, or does it require the medical director's sign-off? SAMHSA's TIP 42 on co-occurring disorders identifies integrated, team-based treatment planning — where psychiatry, therapy, and medical staff review cases jointly — as a marker of higher-quality programming, distinct from parallel or sequential models where mental health and substance use are treated by separate, uncoordinated teams.
"What's Your Success Rate?" → "How Was That Number Calculated, and by Whom?"
This is probably the single most misleading statistic in the entire treatment industry, and it's not always intentional. "Success rate" has no standardized definition. Some centers count anyone who completes the program, regardless of what happens after. Some survey patients at 30 days post-discharge — a window during which almost everyone is still doing reasonably well. Very few track outcomes at 12 months, which is the timeframe that actually matters, since NIDA research consistently shows relapse risk remains substantial well beyond the first month of sobriety.
Ask directly: What percentage of patients did you survey to get that number? What percentage responded? At what point after discharge? Was this measured by an outside researcher or by internal staff with an incentive to report favorably?
A legitimate program will often admit the limitations of its own data — self-selection bias in follow-up surveys, low response rates, the inherent difficulty of tracking people once they leave. That admission is a better sign than a confident, unqualified percentage. A 2020 review in Addiction noted that outcome reporting across private treatment facilities in the U.S. remains largely unregulated and inconsistent, making cross-program comparison nearly impossible without asking these clarifying questions directly.
"Do You Treat Co-Occurring Disorders?" → "What Happens If the Diagnosis Is Wrong?"
Most programs will say yes to treating dual diagnosis cases — anxiety, depression, PTSD, bipolar disorder alongside substance use. Nearly half of people with a substance use disorder also meet criteria for a co-occurring mental health condition, according to SAMHSA's National Survey on Drug Use and Health, so it would be a strange business decision to say no.
The better question: what happens when the intake diagnosis turns out to be incomplete or wrong? Substance use frequently masks or mimics psychiatric symptoms — a person in early withdrawal can look bipolar, a person in protracted use can look depressed in ways that resolve on their own within weeks of abstinence. A well-run program re-evaluates. A rigid one locks in the intake diagnosis and treats it for the full length of stay, regardless of what unfolds clinically.
Ask how often psychiatric assessment is repeated during treatment — intake only, or at defined intervals. Ask whether the treating psychiatrist is on-site or consults remotely, and how quickly a medication change can actually happen if a patient is struggling. "We have a psychiatrist on staff" and "our psychiatrist sees patients twice a week and can adjust medication same-day if needed" are very different statements that get compressed into the same yes.
"What's Included in the Cost?" → "What Happens If My Loved One Needs Longer Than the Contracted Stay?"
Families usually ask about price and insurance coverage — reasonable, necessary questions. Fewer ask what happens at the edges of the contract.
Ask: If 30 days isn't enough, what's the process for extending? Is it a new admission with new costs, or a built-in extension pathway? What's the discharge criteria — is it a fixed calendar date, or a clinical decision made by the treatment team based on readiness?
This matters because length-of-stay research is fairly consistent: NIDA's data has long indicated that treatment durations under 90 days show diminished long-term effectiveness for many patients with more severe or chronic substance use patterns. A program locked into rigid 28-day cycles for financial or logistical reasons — regardless of individual clinical progress — is telling you something about its actual priorities, whatever the marketing copy says about individualized care.
Also ask what's not included. Detox as a separate charge. Family therapy sessions capped at a certain number. Aftermath planning billed separately. The published price and the actual cost of a full episode of care are often two different numbers.
"Can Family Be Involved?" → "What Does Involvement Actually Look Like Week by Week?"
Almost every program says yes to family involvement. Very few explain what that means in practice, and the difference between programs here is enormous.
Does "family involvement" mean one static educational session in week three? A weekly family therapy call with the primary therapist? A structured multi-family group where you'll hear from other people going through the same thing? Research on family-involved treatment — including work associated with the Community Reinforcement and Family Training (CRAFT) model — has found that structured family participation improves engagement and retention rates compared to programs where families are informed but not actively included in the therapeutic process.
Ask specifically: Will you, as the family member, ever speak directly with the primary therapist, or only with a family liaison? How often? Is there a family program with its own curriculum, or informal check-ins scheduled as time permits?
"What Happens After Discharge?" → "Who Is Responsible for Making the Next Appointment Happen?"
Aftercare planning is where most programs' answers sound identical — "we provide a discharge plan" — and where actual practice diverges wildly. A discharge plan that's a printed sheet of local therapist names is not the same as a program that schedules the first outpatient appointment before the patient leaves the building.
The gap between discharge and the first follow-up appointment is exactly where relapse risk spikes. Ask who owns that handoff. Does the center's case manager call and confirm the outpatient appointment is booked, or is it left to the patient — often in the most vulnerable and disorganized week of early recovery — to make that call themselves?
Ask about the specific mechanism for relapse: if your loved one uses again within the first 60 days post-discharge, is there a re-engagement protocol, a direct line to call, or does the relationship functionally end at discharge?
How to Use These Answers
Don't evaluate a single program in isolation and decide based on gut feeling from one phone call. Ask the same follow-up questions of two or three programs and compare the specificity of the answers side by side — vague-versus-vague tells you nothing, but vague-versus-specific is a real signal. Our center directory lets you shortlist programs by location, specialty, and level of care before you start making calls, which makes comparison far more efficient than researching one facility at a time from scratch.
Frequently Asked Questions
Should I ask these questions to the admissions counselor or request the clinical director?
Start with admissions — they handle most inquiries and can answer logistics quickly. But for the deeper clinical follow-ups (diagnosis re-evaluation, treatment team structure, psychiatric access), it's reasonable to ask for a brief call with a clinician or clinical director before committing. A program confident in its own practices will usually accommodate this.
What if the admissions staff can't answer my follow-up questions at all?
That's useful information in itself. It doesn't automatically disqualify a program, but it should prompt you to ask for someone who can answer clinically, and to notice whether that request is met with cooperation or resistance.
Is it rude to ask for specifics about success rates and outcome data?
No. Reputable programs expect and welcome this scrutiny — it's a standard part of due diligence, similar to asking a surgeon about complication rates. Hesitation or defensiveness in response to a straightforward, respectfully asked question is itself worth noting.
How many programs should I compare before deciding?
There's no fixed number, but comparing at least two or three gives you a baseline for what "specific" versus "vague" actually sounds like. A single conversation, especially during a crisis, rarely gives you enough contrast to judge quality accurately.
My loved one has both a mental health diagnosis and a substance use disorder — does that change which questions matter most?
Yes. Prioritize the questions about diagnosis re-evaluation, psychiatric access, and team coordination between mental health and addiction staff. Programs built for dual diagnosis treatment should have detailed, confident answers to these specific questions — hesitation here is a stronger warning sign than in a general-treatment program.
A Final Word
None of these follow-up questions guarantee a good outcome — nothing does. But they shift the decision away from marketing language and toward operational reality, which is the only thing that actually affects your loved one's care. The families who end up satisfied with their choice months later are rarely the ones who found the center with the best website. They're the ones who asked a second question, listened closely to the answer, and trusted what the specificity — or lack of it — actually told them.
RA
Written by
Rehab-Atlas Editorial Team
Our editorial team consists of clinical specialists, addiction counselors, and healthcare writers dedicated to providing accurate, evidence-based information.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment decisions.
Looking for integrated dual-diagnosis care?
Centers that treat addiction and mental health together — at the same time — are rarer than they look.
